找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Immunology; Bench to Bedside Imm Nima Rezaei Book 2021Latest edition Springer Nature Switzerland AG 2021 Cancer immunotherapy.Transl

[复制链接]
楼主: 拖累
发表于 2025-4-1 03:58:52 | 显示全部楼层
发表于 2025-4-1 08:25:10 | 显示全部楼层
Toll-Like Receptor Pathway and Its Targeting in Treatment of Cancers,une responses. In particular, most of the studies have been centered on TLRs that play a pivotal role in tumor biology. TLR activation acts as a double-edged sword with both pro- and antitumor responses. Certain TLRs activate PI3K/Akt pathway, leading to tumor progression. In contrast, few TLRs are
发表于 2025-4-1 12:52:56 | 显示全部楼层
Recent Advances in the Use of NK Cells Against Cancer,or cells, as well as how tumors try to subvert this attack, has led to many new ideas about how to make NK cell immunotherapy more effective. Advances in both technology and methodology have made it possible to generate large numbers of NK cells to utilize in either autologous or allogeneic NK cell
发表于 2025-4-1 14:48:29 | 显示全部楼层
Dendritic Cell Vaccines for Cancer Therapy: Fundamentals and Clinical Trials,s have figured as effective agents of customized medicine. Dendritic cells (DCs) are key cells to trigger an effective antitumor response, being the only antigen-presenting cells (APCs) able to prime naïve T lymphocytes for tumor antigens. Therefore, several approaches have been proposed to use thes
发表于 2025-4-1 19:17:34 | 显示全部楼层
发表于 2025-4-1 22:52:27 | 显示全部楼层
发表于 2025-4-2 04:39:41 | 显示全部楼层
发表于 2025-4-2 09:38:45 | 显示全部楼层
发表于 2025-4-2 12:22:56 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-29 03:25
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表